SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 196.14+2.3%Jan 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24424)8/12/1998 9:51:00 PM
From: JOEBT1  Read Replies (1) of 32384
 
Here is the state of LGND at the end of 1998 based on the events/announcements that may occur from now till the end of the year.
--Psoriasis PII trial well underway (starting end of 3rd QT.) with Panretin or Targretin
--Breast cancer PII trial well underway again starting at end of 3rd QT with Targretin
--PII trial results on ovarian, prostate, kidney, lung reported.
--ONTAK and Panretin approved by FDA.
--Licenses for international marketing of ONTAK and Panretin negotiated with large Pharma.
--PII trial for non-Hodgkins lymphoma underway using ONTAK.
--Targretin PII trial results diabetes reported.
--NDA filed for Targretin gel or Panretin for CTCL.
--New deal/deals announced with major pharma on small molecule alternatives for interlukin,androgens etc.
Henry, I have gleamed the above from your posts and from talking to IR. Please correct and expand. So the big question is what will the market price of LGND be if all the above (no guarantees) happens by the end of the year? I would appreciate your opinion and the opinions of other posters.
.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext